Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 2Recruiting 2Not yet recruiting 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 436Carboplatin 321Nivolumab 286Cyclophosphamide 280Specimen Handling 257Cisplatin 252Magnetic Resonance Spectroscopy 248Paclitaxel 247Radiotherapy 218Dexamethasone 181Gemcitabine 180Biopsy 177durvalumab 166atezolizumab 147Rituximab 138Lenalidomide 134Doxorubicin 134Docetaxel 128Bevacizumab 128Ipilimumab 126Radiation 119Capecitabine 117Pemetrexed 112Oxaliplatin 111Etoposide 111Radiosurgery 108Fluorouracil 107venetoclax 106fludarabine 106Prednisone 97

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Interventional × dupilumab × Clear all
NCT05013450 2025-12-17

Dupilumab_Metastatic NSCLC

Icahn School of Medicine at Mount Sinai

Phase 1/2 Active not recruiting
33 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡